Cytosorbents Corporation (NASDAQ:CTSO) changes shares on Wednesday trading session, with a change of 2.66% or $0.25 shares. The trading starts at $9.46 and closed at $9.41 throughout the day. The trading session low price was $9.32 and day high was $10.12 on Wednesday, August 05. After the session, the Healthcare sector daily volume shifted to 1.15 million while its average volume is 616.18K. In other hand, the CTSO market cap reached to $413.64M. While, its current target price is $15.00.
On May 14, 2018, BRIEF-Cytosorb Adds Bilirubin And Myoglobin Reduction To Eu Approved Indications For Use. According to the news reported on Reuters, * CYTOSORB® ADDS BILIRUBIN AND MYOGLOBIN REDUCTION TO EUROPEAN UNION APPROVED INDICATIONS FOR USE
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -0.10% and down -4.17% for month. Its quarterly performance was -7.56% below, while its half year performance is up 77.90%. CTSO yearly performance stood at positive 47.71% and rise 150.91% for year-to-date. Current recommendation for Cytosorbents Corporation is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CTSO EPS (TTM) for 12-month is -0.55. EPS for this year is -6.60%, while for the next year its value is -0.11. Its EPS Q/Q reached 33.60%. It has an EPS of 14.30% up for past five years.
Let’s take a look on the analyst recommendations on CTSO for the current month and previous month. For the current month, 5 of 5 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings.
The insider ownership moved to 3.50% and institutional holding shifted to 24.50%.
The company posted an EPS (TTM) of -0.55. According to the most recent quarter report on (Sep 2020), 6 analysts estimated an average EPS of -0.09, while -0.21 EPS posted a year ago period. Analyst Estimated EPS for CTSO published in the report was -$0.13 – -$0.06 during the same period. Comparing with last year, the average estimated EPS was -0.21 which is lower than -0.08 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CTSO rise 42.97% for period of 200 days. SMA for 50 days was -1.27% which is showing red signal, while SMA-20 was -3.98%. The moving average value for Cytosorbents Corporation (CTSO) is 2.83M and 7.74% for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in CTSO stock. On Apr 27, Capponi Vincent, Chief Operating Officer, sold 10,000 trading shares at the cost of $10.00, which valued at 100000.0. On Mar 10, Capponi Vincent, Chief Operating Officer, sold 4,677 shares at the cost of $6.00, with total shares of 417,649. On Dec 10, BLOCH KATHLEEN P., Chief Financial Officer, bought 3,000 shares at the cost of 3.68. After this transaction, BLOCH KATHLEEN P. total shares reached to 291,895 which valued at 11030.0.